Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton Lac-Leamy

Oct 26, 2026 7:30 AM - Oct 27, 2026 4:00 PM

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Highlights & Features

What is happening at Canada Annual Meeting



Need Approval in Order to Attend?

Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.



  • Bring together regulators, industry, patients, and academia to exchange perspectives on Canada’s role in global regulatory science
  • Highlight the latest developments in regulation, safety, labeling, trial modernization, and digital transformation
  • Strengthen partnerships between Health Canada, international regulators, industry leaders, and patient representatives
  • Provide learning opportunities across regulatory, clinical, and safety domains to expand participant knowledge and expertise
  • Create space for peer-to-peer exchange through plenaries, breakouts, and dedicated networking sessions

  • Direct access to Health Canada leadership and global regulators
  • Timely updates on evolving regulations, policies, and compliance frameworks
  • Patient-centered perspectives that put lived experience at the heart of discussions
  • Cutting-edge insights on AI, digital submissions, and innovative clinical research models
  • Opportunities to connect with diverse stakeholders across the life sciences ecosystem


Three Educational Tracks: Regulatory, Clinical, Safety and Pharmacovigilance


Track A: Regulatory

This track delves into Canada's evolving regulatory landscape, providing a platform for exchanging insights, practical use cases, and emerging best practices. Sessions will focus on both current and upcoming regulatory requirements, key policy developments, regulatory convergence and innovative strategies that are influencing life sciences R&D in Canada. Sessions will aim to equip attendees with actionable knowledge to effectively navigate regulatory expectations and enhance the quality of submissions in an increasingly complex environment.

Track B: Clinical

This track explores the evolving landscape of clinical research development and operations in Canada, offering a platform to exchange insights, real-world applications, and emerging best practices. Sessions will aim to equip attendees with practical knowledge to successfully design and execute clinical programs in an increasingly complex and fast-paced environment.

Track C: Safety and Pharmacovigilance

This track brings together industry, health authorities, and other stakeholders to share best practices and advance product safety across all product types. Sessions will explore regulatory insights, cross-functional interfaces, and emerging trends and technologies.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.